Isolation of xanthine oxidase inhibitor compounds of pekoe fanning black tea and their activity on interferon-­γ production in vivo

Dadan Rohdiana (1) , Asep Gana Suganda (2) , Komar Ruslan Wirasutisna (3) , Maria Immaculata Iwo (4)
(1) Research Institute for Tea and Cinchona, Gambung PO BOX 1013 Bandung 40010, Indonesia / School of Pharmacy, Bandung Institute of Technology, Jl. Ganesha 10 Bandung 40132, Indonesia, Indonesia ,
(2) Research Institute for Tea and Cinchona, Gambung PO BOX 1013 Bandung 40010, Indonesia, Indonesia ,
(3) Research Institute for Tea and Cinchona, Gambung PO BOX 1013 Bandung 40010, Indonesia, Indonesia ,
(4) Research Institute for Tea and Cinchona, Gambung PO BOX 1013 Bandung 40010, Indonesia, Indonesia

Abstract

Isolation of bioactive compounds on pekoe fanning black tea was done. The isolation was guided by xanthine oxidase (XO) inhibitory activity test. On the fractionation and separation steps, the ethyl acetate fraction and subfraction (SB)-­3 had greater on XO activity with percentage of inhibition 71.38% and 74.49% respectively. The purification  steps  obtained  four  compounds  and  they  were  identified  by  spectral  data  of  UV-­Vis,  1H-­NMR,  MS,  and  13C- NMR. From spectral data the compounds were known as kaempferol, quercetin, luteolin and myricetin. All isolates were assayed by XO inhibitory and their activity on interferon-­γ (IFN-­γ) production in vivo. Luteolin demonstrated  the  greatest  of  XO  inhibitory  activity  with  IC50  5.06  µg/ml.  On  IFN-­γ  production  indicated  that  quercetin demonstrated the greatest ability with IFN-­ γ production 14.45 pg/ml.

Full text article

Generated from XML file

Authors

Dadan Rohdiana
rohdiana@yahoo.com (Primary Contact)
Asep Gana Suganda
Komar Ruslan Wirasutisna
Maria Immaculata Iwo
Dadan Rohdiana, Asep Gana Suganda, Komar Ruslan Wirasutisna, & Maria Immaculata Iwo. (2014). Isolation of xanthine oxidase inhibitor compounds of pekoe fanning black tea and their activity on interferon-­γ production in vivo. International Journal of Research in Pharmaceutical Sciences, 5(4), 240–243. Retrieved from https://ijrps.com/home/article/view/3829

Article Details

No Related Submission Found